Is G Medical Innovations Holdings a Winner in the Medical Device Industry?

: GMVD | G Medical Innovations Holdings Ltd. News, Ratings, and Charts

GMVD – The shares of G Medical (GMVD) have generated weak momentum over the past three months, losing 18.4% in price. And given the company’s weak bottom-line, the question is, will the stock be able to rebound soon? Please keep reading to find out.

G Medical Innovations Holdings Ltd (GMVD) is an Israel-based commercial-stage healthcare company that is developing next-generation mobile health and telemedicine solutions in the United States, China, and Israel.

Shares of GMVD have slumped 18.4% in price over the past three months to close yesterday’s trading session at $2.30. The stock is currently trading above its 50-day moving average of $2.26, but below its 200-day moving average of $2.83.

The global healthcare industry is thriving with increased demand for healthcare products and services and continuing investments in the sector. An aging population is also driving the industry’s growth. So, with rising demand and continued medical advances and innovations, the industry is expected to keep growing. However, GMVD’s bottom-line has yet to reflect the industry tailwinds.

Click here to checkout our Healthcare Sector Report for 2021

The Company’s Expectations

The company expects to target investments in increasing sales and marketing capabilities and expand its medical monitoring technical teams while enhancing its commercial portfolio.

”In support of our growth strategy, we are expanding both Prizma evaluations and cardiac service monitoring opportunities with healthcare providers and expect to see recognition of these activities in 2022,” according to Dr. Yacov Geva, President, and CEO of G Medical Innovations.

But, while the company is preparing for long-term growth, focusing on synergistic acquisitions, its bottom-line growth could be limited in the near term. The company used less cash in operations in the first half of 2021 than the prior-year period.

Weak Bottom-Line

GMVD’s total revenues increased 45.5% year-over-year to $2.93 million for the six months ended June 30. Its operating loss stood at $4.27 million, down 7.8% from the same period last year. Its loss for the period came in at $4.77 million, indicating a decline of 4.2% year-over-year. In addition, its loss per share declined 39.3% year-over-year to $0.51.

POWR Ratings Reflect Bleak Prospects

GMVD has an overall D rating, which translates to Sell in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

The stock has a D grade for Momentum. This is justified because  the stock has lost 12.3% in price over the past three months.

GMVD has a C grade for Growth. Its mixed financials for the first half of 2021 justify this grade.

Of the 172 stocks in the Medical – Devices & Equipment industry, GMVD is ranked #144.

Beyond what I have stated above, one can also view GMVD’s grades for Quality, Value, Sentiment, and Stability here.

View the top-rated stocks in the Medical – Devices & Equipment industry here.

Conclusion

Although the healthcare industry has garnered huge investor attention since the onset of the pandemic, GMVD has not yet  benefited sufficiently from the industry tailwinds, which is reflected in its bottom line. Furthermore, the stock’s price performance has also been weak, representing investors’ pessimism. So, we think the stock is best avoided now.

How Does G Medical Innovations Holdings Ltd (GMVD) Stack Up Against its Peers?

While GMVD has an overall POWR Rating of D, one might want to consider investing in stocks holding an A (Strong Buy) rating, such as Fonar Corporation (FONR), Natus Medical Incorporated (NTUS), and Utah Medical Products, Inc. (UTMD).

Click here to checkout our Healthcare Sector Report for 2021


GMVD shares were unchanged in premarket trading Friday. Year-to-date, GMVD has declined -7.60%, versus a 26.56% rise in the benchmark S&P 500 index during the same period.


About the Author: Subhasree Kar


Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GMVDGet RatingGet RatingGet Rating
FONRGet RatingGet RatingGet Rating
NTUSGet RatingGet RatingGet Rating
UTMDGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

3 Energy Stocks Set to Soar Beyond Expectations

Given the geopolitical tensions, increasing global oil demand, and supply adjustments, the energy sector is poised for robust growth. Therefore, investors might consider investing in energy stocks TechnipFMC (FTI), Weatherford International (WFRD), and ChampionX (CHX), which are poised to exceed expectations. Keep reading…

Has Carnival (CCL) Stock Turned Into a Buy After Earnings Release?

Carnival Corporation (CCL) reported record revenue in its most recent quarter but still faces a negative bottom line. The collapse of Francis Scott Key Bridge brings more uncertainty to its financials. Given these events, what stance should one take with CCL stock? Read more to find out…

3 China Stocks Positioned for Long-Term Growth

Despite facing challenges, the Chinese economy has demonstrated resilience, as evidenced by recent robust industrial output and retail sales data. Given this outlook, it might be an opportune time to own three top-notch China stocks, JD.com, Inc. (JD), China Automotive Systems (CAAS), and Youdao, Inc. (DAO). Read on…

What Data Should Investors Focus on Now?

The S&P 500 (SPY) is up nearly 50% from the bear market lows. That is a sign the easy money has been made. The next likely catalyst for stocks will probably be the first Fed rate cut...but maybe that is really the final push before a long overdue sell off? Tune in to discover what investment veteran Steve Reitmeister has to say about the market outlook along with his trading plan and top picks to stay ahead of the pack. Read on below for more...

Read More Stories

More G Medical Innovations Holdings Ltd. (GMVD) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GMVD News